Prognostic factors for in-transit metastasis in patients with malignant melanoma.

Autor: Gâta VA; Department of Oncology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuta' Institute of Oncology, Cluj-Napoca, Romania., Roman A; Department of Radiology, 'Prof. Dr. Ion Chiricuta' Institute of Oncology, Cluj-Napoca, Romania., Muntean M; Department of Oncology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuta' Institute of Oncology, Cluj-Napoca, Romania., Morariu DŞ; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuta' Institute of Oncology, Cluj-Napoca, Romania., Vlad CI; Department of Oncology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuta' Institute of Oncology, Cluj-Napoca, Romania., Bonci EA; Department of Oncology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuta' Institute of Oncology, Cluj-Napoca, Romania., Irimie A; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuta' Institute of Oncology, Cluj-Napoca, Romania.; The Academy of Medical Sciences, Cluj-Napoca Branch, Romania., Achimaş-Cadariu P; Department of Oncology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuta' Institute of Oncology, Cluj-Napoca, Romania.

Publikováno v: Medicine and pharmacy reports [Med Pharm Rep] 2022 Jan; Vol. 95 (1), pp. 40-46. Date of Electronic Publication: 2022 Jan 31.